stockrowAxoGen, Inc. (AXGN) vs TransMedics Group, Inc. (TMDX)
- AxoGen, Inc. AXGN 49.88 +2.32%
- TransMedics Group, Inc. TMDX 85.10 +23.37%
AxoGen, Inc. and TransMedics Group, Inc. are both Medical Devices companies. AxoGen, Inc. is the larger, with a market value of $2.9B against $2.4B — 1.2× the size. AxoGen, Inc. has negative trailing earnings, so its P/E is not meaningful; TransMedics Group, Inc. trades at 16.4×. TransMedics Group, Inc. grew revenue faster over the last twelve months: 28.5% against 24.3%. TransMedics Group, Inc. has the higher net margin (19.9% vs −12.0%) and the higher return on invested capital (48.0% vs −5.27%). Across the 19 metrics below, TransMedics Group, Inc. leads on 15 and AxoGen, Inc. on 4.
Valuation
Profitability
| Metric | AXGN | TMDX | Medical Devices median |
|---|---|---|---|
| Gross margin | 74.18% | 58.60% | 57.76% |
| Operating margin | (5.17%) | 11.88% | (15.07%) |
| Net margin | (11.96%) | 19.85% | (14.45%) |
| Free cash flow margin | 7.50% | 6.14% | (3.88%) |
| Return on equity | (10.35%) | 31.89% | (10.35%) |
| Return on assets | (8.33%) | 11.73% | (17.26%) |
| Return on invested capital | (5.27%) | 48.00% | (5.27%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack